Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This 12-month study will evaluate the efficacy of aripiprazole lauroxil compared to oral aripiprazole in preventing the re-emergence of psychotic symptoms in patients with a recent onset of schizophrenia.
Epistemonikos ID: 96ca0cfef71b9ae3945f86225be8fa0ff3274be6
First added on: May 06, 2024